Literature DB >> 8845608

Skip metastasis and hidden N2 disease in lung cancer: how successful is mediastinal dissection?

N Tsubota1, M Yoshimura.   

Abstract

Out of 703 consecutive patients who underwent lung cancer surgery from 1986 to 1994, 562 were studied with an emphasis on lymph node metastasis. Skip metastasis was defined as metastasis to the upper mediastinum without involvement of the carinal, hilar, or intrapulmonary nodes. Twenty-nine patients had skip metastasis, accounting for 17% of the 175 with N2 disease. Except for one patient with a huge tumor, there was no lower-lobe disease. Patients with N2 disease nodes were categorized into the following groups: (1) 32 with false negative N2 that could not be detected macroscopically on the specimen; (2) 64 with true positive N2, detected macroscopically on the specimen; and (3) 79 patients with obvious N2. Positive carinal nodes were found in 12 of 70 N2 patients who underwent upper lobectomy, and in 60 of the (105) remaining N2 patients who had other types of surgery. We conclude that upper mediastinal dissection should be carried out in patients with adenocarcinoma in the upper lobe, because skip and undetectable metastasis are not rare. However, dissection of the carinal nodes with upper-lobe tumors, and of the upper mediastinum with lower-lobe tumors, can be omitted when the gross and frozen section findings are negative in the upper mediastinum and both the carinal and hilar nodes.

Entities:  

Mesh:

Year:  1996        PMID: 8845608     DOI: 10.1007/bf00311501

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  The importance of radical lobectomy in lung cancer.

Authors:  H E Ramsey; W G Cahan; E J Beattie; C Humphrey
Journal:  J Thorac Cardiovasc Surg       Date:  1969-08       Impact factor: 5.209

2.  Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

Authors:  F G Pearson; N C DeLarue; R Ilves; T R Todd; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1982-01       Impact factor: 5.209

3.  Patterns of mediastinal metastases in bronchogenic carcinoma.

Authors:  H I Libshitz; R J McKenna; C F Mountain
Journal:  Chest       Date:  1986-08       Impact factor: 9.410

4.  Site, size, and tumour involvement of resected extrapulmonary lymph nodes in lung cancer.

Authors:  K Kayser; S Bach; H Bülzebruck; I Vogt-Moykopf; G Probst
Journal:  J Surg Oncol       Date:  1990-01       Impact factor: 3.454

5.  The importance of surgery to non-small cell carcinoma of lung with mediastinal lymph node metastasis.

Authors:  T Naruke; T Goya; R Tsuchiya; K Suemasu
Journal:  Ann Thorac Surg       Date:  1988-12       Impact factor: 4.330

6.  Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases.

Authors:  N Martini; B J Flehinger; M B Zaman; E J Beattie
Journal:  Ann Surg       Date:  1983-09       Impact factor: 12.969

  6 in total
  8 in total

1.  Detection of pleural lymph flow using indocyanine green fluorescence imaging in non-small cell lung cancer surgery: a preliminary study.

Authors:  Kazuhiro Imai; Yoshihiro Minamiya; Hajime Saito; Taku Nakagawa; Manabu Ito; Takashi Ono; Satoru Motoyama; Yusuke Sato; Hayato Konno; Jun-ichi Ogawa
Journal:  Surg Today       Date:  2012-06-23       Impact factor: 2.549

2.  Intentional limited resection for small peripheral lung cancer based on intraoperative pathologic exploration.

Authors:  Takehiro Watanabe; Akira Okada; Takayuki Imakiire; Terumoto Koike; Tatsuhiko Hirono
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2005-01

3.  Immunohistochemical evidence that P-glycoprotein in non-small cell lung cancers is associated with shorter survival.

Authors:  H Yokoyama; T Ishida; K Sugio; T Inoue; K Sugimachi
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Is lower zone mediastinal nodal dissection always mandatory for lung cancer in the lower lobe?

Authors:  Hiroyasu Ueno; Aritoshi Hattori; Takeshi Matsunaga; Kazuya Takamochi; Shiaki Oh; Kenji Suzuki
Journal:  Surg Today       Date:  2015-01-27       Impact factor: 2.549

5.  Detection of alternative subpleural lymph flow pathways using indocyanine green fluorescence.

Authors:  Aya Harada Takeda; Yui Watanabe; Toshiyuki Nagata; Masaya Aoki; Tadashi Umehara; Soichi Suzuki; Go Kamimura; Kazuhiro Wakida; Tsunayuki Otsuka; Naoya Yokomakura; Kota Kariatsumari; Koichi Sakasegawa; Yoshihiro Nakamura; Masami Sato
Journal:  Surg Today       Date:  2018-01-30       Impact factor: 2.549

6.  Risk factors for relapse of resectable pathologic N2 non small lung cancer and prediction model for time-to-progression.

Authors:  Chih-Tsung Wen; Jui-Ying Fu; Ching-Feng Wu; Yun-Hen Liu; Ching-Yang Wu; Ming-Ju Hsieh; Yi-Cheng Wu; Ying-Huang Tsai
Journal:  Biomed J       Date:  2017-03-21       Impact factor: 4.910

7.  [Survival Analysis of Stage I Non-small Cell Lung Cancer Patients Treated with 
Da Vinci Robot-assisted Thoracic Surgery].

Authors:  Xingchi Liu; Shiguang Xu; Bo Liu; Wei Xu; Renquan Ding; Tong Wang; Bo Li; Xilong Wang; Qiong Wu; Hong Teng; Shumin Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2018-11-20

8.  Metastatic Patterns of Mediastinal Lymph Nodes in Small-Size Non-small Cell Lung Cancer (T1b).

Authors:  Yijun Wu; Chang Han; Liang Gong; Zhile Wang; Jianghao Liu; Xinyu Liu; Xinyi Chen; Yuming Chong; Naixin Liang; Shanqing Li
Journal:  Front Surg       Date:  2020-09-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.